Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluconazole for Prevention of Chemoradiation-associated Oral Mucositis in Head and Neck Cancer
jRCTs031190265Completed
- Sponsor
- Japan Society for the Promotion of Science
- Start
- Apr 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of fluconazole in stomatitis and head and neck squamous cell carcinoma (HNSCC), sponsored by Japan Society for the Promotion of Science. Primary endpoint: Severe oral mucositis. Started Apr 2020; status: completed.
02
Drugs
fluconazole
03
Conditions
stomatitishead and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on jRCTs031190265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031190265.